Clinical trials
Recruiting Phase 3 Kidney Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Cerium Pharmaceuticals, Inc. | 1 |
| Dimerix Bioscience Pty Ltd | 1 |
| Eli Lilly and Company | 1 |
| Takeda | 1 |
| The University of Queensland | 1 |
| University Hospital, Tours | 1 |
| University of California, San Francisco | 1 |
| University of Leipzig | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 10 |
| Renal Insufficiency, Chronic | 3 |
| Glomerulonephritis | 2 |
| Glomerulonephritis, IGA | 2 |
| Nephritis | 2 |
| Urologic Diseases | 2 |
| Autoimmune Diseases | 1 |
| Female Urogenital Diseases | 1 |
| Female Urogenital Diseases and Pregnancy Complications | 1 |
| Glomerulosclerosis, Focal Segmental | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.